Workflow
MAP App
icon
Search documents
CareCloud Unveils Next-Generation MAP App at HFMA Revenue Cycle Conference
Globenewswire· 2026-03-18 12:00
Core Insights - CareCloud, Inc. will participate in the HFMA Revenue Cycle Conference in Arlington, Texas, showcasing its MAP App, a web-based revenue cycle benchmarking tool [1] - The company has enhanced MAP App's capabilities since acquiring it from HFMA, providing deeper insights into revenue cycle performance for healthcare organizations [2][3] Company Developments - CareCloud has focused on improving MAP App with new development capabilities and a clear product roadmap to deliver value to healthcare organizations [3] - A networking happy hour will be hosted by CareCloud during the conference, aimed at connecting revenue cycle professionals and MAP App users [4][7] Webinar and Educational Initiatives - For those unable to attend the conference, CareCloud will conduct a live webinar on April 7, 2026, covering recent updates and best practices for using MAP App [4][5][8] - The webinar will address how organizations can leverage MAP App to identify revenue cycle improvement opportunities and compare metrics against peer facilities [8] About CareCloud - CareCloud offers a suite of AI and technology-enabled solutions aimed at enhancing financial and operational performance in healthcare [10] - The company serves over 45,000 providers, helping them improve patient care while reducing administrative burdens and operating costs [10]
CareCloud Unveils Next-Generation MAP App at HFMA Revenue Cycle Conference
Globenewswire· 2026-03-18 12:00
Core Insights - CareCloud, Inc. will attend the HFMA Revenue Cycle Conference in Arlington, Texas, showcasing the evolution of its MAP App, a web-based revenue cycle benchmarking tool [1][2] - The company has invested in expanding MAP App's capabilities since its acquisition from HFMA, enhancing visibility into revenue cycle performance for healthcare organizations [2][3] Company Developments - CareCloud's MAP App is recognized as a trusted resource for healthcare organizations aiming to improve revenue cycle performance, with a focus on new development capabilities and a clear product roadmap [3] - The company will host a networking happy hour during the conference, aimed at connecting revenue cycle professionals and MAP App users [4][7] Webinar and Educational Initiatives - For those unable to attend the conference, CareCloud will conduct a live webinar on April 7, 2026, covering recent updates and real-world use cases of MAP App [4][5] - The webinar will address best practices for leveraging MAP App benchmarking data and how organizations can identify revenue cycle improvement opportunities [8] About CareCloud - CareCloud provides AI and technology-enabled solutions to enhance financial and operational performance in healthcare, serving over 45,000 providers [9]
CareCloud(CCLD) - 2025 Q4 - Earnings Call Transcript
2026-03-12 13:32
Financial Data and Key Metrics Changes - For the full year 2025, the company generated revenue of $120.5 million, representing nearly 9% year-over-year growth [7] - In Q4 2025, revenue reached $34.4 million, up nearly 22% year-over-year, indicating accelerating momentum [7] - GAAP net income for 2025 was $10.8 million, a year-over-year increase of more than 37%, with earnings per share of $0.10 [7] - Adjusted EBITDA expanded to $27.5 million with a 23% margin, up more than 14% year-over-year [8] - Free cash flow for 2025 reached approximately $20.5 million, compared to $13.2 million in 2024, representing growth of more than 500% from 2023 [8] Business Line Data and Key Metrics Changes - The company completed multiple acquisitions in 2025, including Medsphere Systems, which expanded its capabilities into the inpatient hospital market [10] - The integration of AI tools into the platform has already resulted in new customer wins under the CareCloud umbrella [11] - The company aims to penetrate newly acquired health system customers with its RCM and AI products as part of its 2026 growth strategy [12] Market Data and Key Metrics Changes - The healthcare technology market is at an inflection point, with AI adoption moving from pilot programs to production deployment [12] - The company recognizes a multi-billion-dollar addressable opportunity in the U.S. for its AI front desk assistant [12] Company Strategy and Development Direction - The company’s 2026 growth strategy focuses on leveraging its dual platform footprint in ambulatory and inpatient markets to drive organic growth and acquisition synergies [13] - Strategic acquisitions have been a cornerstone of growth, with a disciplined approach to acquiring companies at attractive valuations [14] - The company plans to remain active in M&A in 2026 and beyond, identifying complementary targets that can benefit from its AI capabilities [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue guidance of $128 million to $130 million for 2026, with adjusted EBITDA of $29 million to $31 million [15] - The company anticipates GAAP EPS of $0.20 to $0.23 per share, representing an increase of more than 100% over 2025 [15] - Management highlighted the importance of disciplined execution, innovation, and creating long-term value for stakeholders [35] Other Important Information - The company resumed dividends on its preferred shares at the beginning of 2025 and plans to pay double dividends on Series B preferred stock starting in 2026 [9] - The conversion of approximately 80% of Series A preferred shares into common eliminated more than $7 million in annual dividend obligations [9] Q&A Session Summary Question: Can you expand on how you're planning on monetizing AI in 2026? - Management discussed the favorable M&A environment and the strategy to integrate AI capabilities into acquired platforms, enhancing their attractiveness and market position [38][41] Question: What was behind the recent contract wins with new customers? - Management noted the expansion of the sales and marketing team and the focus on cross-selling and upselling existing customers, particularly those acquired through recent transactions [45][46] Question: How should investors think about CareCloud's exposure to AI disruption? - Management emphasized that the company operates in a niche healthcare IT space with deep industry moats, making it less vulnerable to generic AI disruptions [54][56] Question: What are the focuses for the use of excess cash flow? - Management indicated that the focus would be on acquisitions, enhancing the capital structure, and investing in AI development [73] Question: Who are the company's main competitors? - Management identified competitors in the EHR space such as eClinicalWorks and athenahealth, and noted that the AI competitive landscape is broader, with some players lacking a vertical approach [75][78]
CareCloud(CCLD) - 2025 Q4 - Earnings Call Transcript
2026-03-12 13:32
Financial Data and Key Metrics Changes - For the full year 2025, the company generated revenue of $120.5 million, representing nearly 9% year-over-year growth [7] - In Q4 2025, revenue reached $34.4 million, up nearly 22% year-over-year, indicating accelerating momentum [7] - GAAP net income for 2025 was $10.8 million, a year-over-year increase of more than 37%, with earnings per share of $0.10 [7] - Adjusted EBITDA expanded to $27.5 million with a 23% margin, up more than 14% year-over-year [8] - Free cash flow reached approximately $20.5 million for 2025, compared to $13.2 million in 2024, representing growth of more than 500% from 2023 [8] Business Line Data and Key Metrics Changes - The company completed multiple acquisitions in 2025, including Medsphere Systems, which expanded its capabilities into the inpatient hospital market [10] - The integration of AI tools into the platform has already resulted in new customer wins under the CareCloud umbrella [11] - The company aims to penetrate newly acquired health system customers with its RCM and AI products as part of its 2026 growth strategy [12] Market Data and Key Metrics Changes - The healthcare technology market is at an inflection point, with AI adoption moving from pilot programs to production deployment [12] - The company recognizes a multi-billion-dollar addressable opportunity in the U.S. for its AI front desk assistant [12] Company Strategy and Development Direction - The company’s 2026 growth strategy focuses on leveraging its dual platform footprint in ambulatory and inpatient markets to drive organic growth and acquisition synergies [13] - Strategic acquisitions have been a cornerstone of growth, with a disciplined approach to acquiring companies at attractive valuations [14] - The company plans to remain active in M&A in 2026 and beyond, identifying complementary targets that can benefit from its AI capabilities [14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue guidance of $128 million-$130 million for 2026, with adjusted EBITDA of $29 million-$31 million [15] - The company anticipates GAAP EPS of $0.20-$0.23 per share, representing an increase of more than 100% over 2025 [15] - Management highlighted the importance of disciplined execution and innovation to create long-term value for stakeholders [35] Other Important Information - The company resumed dividends on its preferred shares at the beginning of 2025 and plans to pay double dividends on Series B preferred stock starting in 2026 [9] - The conversion of approximately 80% of Series A preferred shares into common eliminated more than $7 million in annual dividend obligations [9] Q&A Session Summary Question: Can you expand on how you're planning on monetizing AI in 2026? - Management discussed the favorable M&A environment and the strategy to integrate AI capabilities into acquired platforms to enhance their attractiveness and market position [38][41] Question: What was behind the recent contract wins and future opportunities? - Management noted the expansion of the sales team and the focus on cross-selling additional services to existing clients acquired through recent transactions [45][46] Question: How does CareCloud's exposure to AI disruption compare to being an AI beneficiary? - Management emphasized that CareCloud operates in a niche healthcare IT space with deep industry moats, making it less vulnerable to generic AI disruptions [54][56] Question: What are the focuses for the use of excess cash flow? - Management indicated that the focus would be on acquisitions, enhancing capital structure, and investing in AI development [73] Question: Who are CareCloud's main competitors? - Management identified competitors in the EHR space such as eClinicalWorks and athenahealth, and noted that the AI competitive landscape varies depending on the product [75][76]
CareCloud(CCLD) - 2025 Q4 - Earnings Call Transcript
2026-03-12 13:30
Financial Data and Key Metrics Changes - For the full year 2025, the company generated revenue of $120.5 million, representing nearly 9% year-over-year growth, with Q4 revenue of $34.4 million, up nearly 22% year-over-year [6][32] - GAAP net income for 2025 was $10.8 million, a year-over-year increase of more than 37%, with earnings per share of $0.10, marking the first full year of positive EPS since the 2014 IPO [6][31] - Adjusted EBITDA expanded to $27.5 million with a 23% margin, up more than 14% year-over-year [7][33] - Free cash flow reached approximately $20.5 million for 2025, compared to $13.2 million in 2024, representing growth of more than 500% from 2023 [7][34] Business Line Data and Key Metrics Changes - The company completed multiple acquisitions in 2025, including Medsphere Systems, which expanded its capabilities into the inpatient hospital market [9][10] - Revenue related to the Medsphere acquisition in Q4 was approximately $7.2 million [32] Market Data and Key Metrics Changes - The healthcare technology market is at an inflection point, with AI adoption moving from pilot programs to production deployment, creating a multi-billion-dollar addressable opportunity in the U.S. [11][12] - The company aims to leverage its dual platform footprint in ambulatory and inpatient markets to drive organic growth and acquisition synergies [12] Company Strategy and Development Direction - The 2026 growth strategy focuses on penetrating newly acquired health system customers with RCM and AI products, emphasizing operating leverage from strategic investments [11][14] - The company plans to remain active in M&A in 2026 and beyond, identifying complementary targets that can benefit from its AI capabilities [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue guidance of $128 million-$130 million for 2026, with adjusted EBITDA of $29 million-$31 million and GAAP EPS of $0.20-$0.23 per share, representing over 100% growth from 2025 [14][15] - The company highlighted its strong financial position, with zero drawn on its credit line and a focus on disciplined execution and innovation [15][34] Other Important Information - The company resumed dividends on preferred shares in early 2025 and began paying double dividends on Series B preferred stock starting in 2026 [8][31] - The AI Center of Excellence was launched in April 2025, focusing on building AI solutions that create measurable impact for healthcare providers [17][18] Q&A Session Summary Question: Can you expand on how you're planning on monetizing AI in 2026? - Management discussed the favorable M&A environment and the strategy to integrate AI capabilities into acquired platforms, enhancing their attractiveness and market position [39][41] Question: What was behind the recent contract wins and future opportunities? - The company has expanded its sales and marketing team, focusing on cross-selling and upselling to existing customers acquired through recent transactions [45][46] Question: How should investors think about CareCloud's exposure to AI disruption? - Management emphasized that CareCloud operates in a niche healthcare IT market with deep industry moats, making it less vulnerable to generic AI disruptions [54][55] Question: What are the focuses for the use of excess cash flow? - The company aims to use excess cash flow for acquisitions, enhancing capital structure, and investing in AI development [73][74] Question: Who are CareCloud's main competitors? - Competitors include eClinicalWorks, AdvancedMD, and athenahealth in the EHR space, with a wider field in AI solutions [75][76]
CareCloud to Present at the 2025 Maxim Growth Summit
Globenewswire· 2025-10-15 12:00
Core Insights - CareCloud will participate in the 2025 Maxim Growth Summit, focusing on acquisitions, growth, and AI strategy [1] - Maxim Group named CareCloud its 'Top Healthcare IT Pick for 2025' due to its AI strategy, strong financial results, and renewed M&A activity [2] Company Developments - CareCloud has closed four M&A transactions year-to-date, including the acquisition of Medsphere and HFMA's MAP App [9] - The AI Center of Excellence was launched earlier this year and aims to scale to approximately 500 AI professionals to enhance innovation in EHR, RCM, analytics, and patient engagement [9] - Revenue guidance for 2025 has been raised to $116–$118 million, reflecting strong execution [9] - CareCloud has been added to the Russell Microcap Index, which is expected to broaden investor awareness [9] Product and Service Offerings - CareCloud provides a suite of AI and technology-enabled solutions aimed at improving financial and operational performance, streamlining clinical workflows, and enhancing patient experience [5] - The company serves over 40,000 providers, helping them reduce administrative burdens and operating costs [5]
CareCloud Announces Acquisition of HFMA’s MAP App to Expand AI-Driven Benchmarking in Hospitals and Integrated Health Systems
Globenewswire· 2025-09-29 12:00
Core Insights - CareCloud has announced a definitive agreement to acquire MAP App, a leading hospital benchmarking tool developed by HFMA, which is set to close on October 1, 2025 [1][2] - The acquisition is part of CareCloud's strategy to enhance its SaaS-based ecosystem and expand its AI-driven healthcare technology solutions [2][3] - The partnership with HFMA aims to improve revenue cycle management performance and provide actionable insights for hospitals [3] Company Overview - CareCloud is a leader in AI-driven healthcare technology solutions, serving hospitals, integrated health systems, and medical practices across the United States [1][5] - The company offers a suite of solutions including revenue cycle management, practice management, electronic health records, and patient experience management [5] - More than 40,000 providers rely on CareCloud to enhance patient care while reducing administrative burdens and operating costs [5] Industry Context - MAP App is recognized as an industry-leading tool for benchmarking revenue cycle management performance, utilized by top hospitals and healthcare organizations nationwide [2] - HFMA, the organization behind MAP App, is the leading membership organization for healthcare finance leaders, providing tools and insights to improve financial outcomes in healthcare [3]